Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: VIA THERAPEUTICS, LLC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2018-08-09 to 2023-08-14
Current total value of award: $3599145
Description: IPP - INHALED DELIVERY OF CLOFAZIMINE - A HIGH EFFICIENCY, FLOW INDEPENDENT, TARGETED, LOW COST DPI